AU2003258922A1 - PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY - Google Patents
PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITYInfo
- Publication number
- AU2003258922A1 AU2003258922A1 AU2003258922A AU2003258922A AU2003258922A1 AU 2003258922 A1 AU2003258922 A1 AU 2003258922A1 AU 2003258922 A AU2003258922 A AU 2003258922A AU 2003258922 A AU2003258922 A AU 2003258922A AU 2003258922 A1 AU2003258922 A1 AU 2003258922A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrazolo
- inhibitors
- kinase activity
- itk kinase
- cinnoline compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202461A SE0202461D0 (en) | 2002-08-14 | 2002-08-14 | Novel compounds |
SE0202461-0 | 2002-08-14 | ||
PCT/SE2003/001278 WO2004016615A1 (en) | 2002-08-14 | 2003-08-13 | PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003258922A1 true AU2003258922A1 (en) | 2004-03-03 |
Family
ID=20288749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003258922A Abandoned AU2003258922A1 (en) | 2002-08-14 | 2003-08-13 | PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003258922A1 (en) |
SE (1) | SE0202461D0 (en) |
WO (1) | WO2004016615A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7465795B2 (en) | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
WO2007073283A1 (en) * | 2005-12-20 | 2007-06-28 | Astrazeneca Ab | Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
WO2007126913A1 (en) * | 2006-03-27 | 2007-11-08 | The Government Of The U.S.A. As Represented By The Secretary Department Of Health & Human Services | Methods for prevention or treatment of viral disease |
WO2013153539A1 (en) | 2012-04-13 | 2013-10-17 | Glenmark Pharmaceuticals S.A. | Tricyclic compounds as tec kinase inhibitors |
CA2928721C (en) | 2013-10-25 | 2020-12-22 | Pharmacyclics Llc | Use of ibrutinib for treating and preventing chronic graft versus host disease |
MA45973A (en) | 2015-08-31 | 2019-06-26 | Pharmacyclics Llc | BTK INHIBITOR COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA |
CN110139669A (en) | 2016-11-03 | 2019-08-16 | 朱诺治疗学股份有限公司 | The combination treatment of T cell therapy and BTK inhibitor |
PE20200608A1 (en) | 2017-06-30 | 2020-03-10 | Bayer Animal Health Gmbh | NEW DERIVATIVES OF AZAQUINOLINE |
JP7410877B2 (en) | 2018-05-03 | 2024-01-10 | ジュノー セラピューティクス インコーポレイテッド | Combination therapy of chimeric antigen receptor (CAR) T cell therapy and kinase inhibitors |
WO2023220655A1 (en) | 2022-05-11 | 2023-11-16 | Celgene Corporation | Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2549833B1 (en) * | 1983-07-26 | 1985-11-08 | Roussel Uclaf | PYRAZOLO / 4,3-C / CINNOLIN-3-ONE DERIVATIVES, SALTS THEREOF, PROCESS FOR PREPARATION, APPLICATION AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES |
JPS61112075A (en) * | 1984-11-05 | 1986-05-30 | Shionogi & Co Ltd | Thienylpyrazoloquinoline derivative |
US4591589A (en) * | 1985-01-16 | 1986-05-27 | Roussel Uclaf | 2-aryl pyrazolo[4,3-c]cinnolin-3-ones |
-
2002
- 2002-08-14 SE SE0202461A patent/SE0202461D0/en unknown
-
2003
- 2003-08-13 AU AU2003258922A patent/AU2003258922A1/en not_active Abandoned
- 2003-08-13 WO PCT/SE2003/001278 patent/WO2004016615A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE0202461D0 (en) | 2002-08-14 |
WO2004016615A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002357773A1 (en) | 1,6 naphthyridines useful as inhibitors of syk kinase | |
AU2003271566A1 (en) | Pyrrolopyrazines as kinase inhibitors | |
EP1436290B8 (en) | Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor | |
AU2003265349A1 (en) | Pyrrolotriazine kinase inhibitors | |
EP1689393A4 (en) | Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors | |
AU2003222055A1 (en) | Kinase inhibitors | |
PL376844A1 (en) | Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) | |
AU2003286711A1 (en) | Indazolinone compositions useful as kinase inhibitors | |
PT1690853E (en) | Use of omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
AU2003275282A1 (en) | Novel tyrosine kinase inhibitors | |
AU2002361577A1 (en) | Tyrosine kinase inhibitors | |
AU2003237446A1 (en) | Pyrazole-derivatives as p38 kinase inhibitors | |
AU2003254051A1 (en) | Pyrazolopyrimidines as kinase inhibitors | |
AU2002348394A1 (en) | Tyrosine kinase inhibitors | |
AU2003261204A1 (en) | Pyrazolopyrimidines as kinase inhibitors | |
AU2003258922A1 (en) | PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY | |
AU2002348393A1 (en) | Tyrosine kinase inhibitors | |
AU2002323406A1 (en) | Tyrosine kinase inhibitors | |
AU2003249535A1 (en) | 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors | |
AU2003215635A1 (en) | Thiazol-2-yl-imine compounds as pde-7 inhibitors | |
AU2003250465A1 (en) | 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors | |
AU2002253350A1 (en) | 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors | |
AUPS251402A0 (en) | Kinase inhibitors | |
AU2003293886A1 (en) | (1,7)naphthyridines as pde4 inhibitors | |
AU2003300551A8 (en) | Compounds for the inhibition of non-proteolytic enzymes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |